Obesity Drug Wegovy Now Available in Oral Form

Wegovy, a widely-used obesity treatment, is now available in oral tablet form. The medication, manufactured by Novo Nordisk, was previously only available as an injectable. The new oral form will be available in pharmacies.

The oral tablets will be available in 2.4 mg and 4.8 mg doses. The 2.4 mg tablets are intended for initial use, with patients later transitioning to the 4.8 mg dose. The oral form is designed to be taken once daily, with or without food.

Novo Nordisk reports that the oral form of Wegovy has been approved by the relevant authorities. The company has stated that the oral tablets are as effective as the injectable form, with similar side effects. The most common side effects include nausea, diarrhea, and constipation.

Healthcare professionals have welcomed the new oral form, citing its potential to improve patient adherence to treatment. The injectable form of Wegovy requires weekly administration, which can be inconvenient for some patients. The oral form, taken daily, may encourage more consistent use.

Novo Nordisk has not yet announced the price of the oral tablets. However, the company has stated that it is committed to making the medication accessible and affordable. The injectable form of Wegovy is currently priced at around $1,300 per month in the United States.

The oral form of Wegovy is expected to be available in pharmacies in the coming weeks. Novo Nordisk has stated that it is working with pharmacies to ensure a smooth transition for patients currently using the injectable form.